Expanding Diagnostic Range Agilus Diagnostics is continuously expanding its test offerings, including advanced molecular and genetic assays, pharmacogenomics, and specialized tests like Anti-MCV and D-DISH, creating opportunities to cross-sell these innovative diagnostic solutions to hospitals and clinics seeking comprehensive testing capabilities.

International Market Presence With a strong presence across the SAARC region, Sub-Saharan Africa, Southeast Asia, and the Middle East, there is significant potential to develop partnerships and sales channels for international export of advanced diagnostics, including their latest tests and sequencing panels.

Technological Integration The company's adoption of advanced tech tools such as Lucence for oncology testing and strategic digital marketing indicates an openness to integrating new health tech solutions — presenting opportunities to introduce complementary health IT systems, laboratory automation, and data management solutions.

Corporate Collaborations Recent partnerships with Sebia and the Indian Olympic Association highlight Agilus's focus on high-profile collaborations, which can be leveraged to promote premium testing services, expand customer base, and develop co-branded health initiatives targeting niche markets and elite segments.

Financial Opportunity With a revenue base exceeding one billion dollars and a robust network of accredited labs and customer touchpoints across India and beyond, there is strong potential for upselling specialized diagnostic packages, enterprise solutions, and customized testing services to large hospitals, corporate health programs, and government institutions.